Best first-line therapy for patients with advanced non-small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status
- Gijtenbeek, Rolof G.P.
- de Jong, Kim
- Venmans, Ben J.W.
- van Vollenhoven, Femke H.M.
- Brinke, Anneke Ten
- Van der Wekken, Anthonie J.
- van Geffen, Wouter H.
DOIAbstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To identify the best first-line therapy for advanced lung cancer in patients with performance status 2 without a targetable mutation or with an unknown mutation status
Add to ORKG